Molecular Docking Evaluation of the Desert Truffles as Potent Antifungal Inhibitors

Al-Mazaideh, Ghassab M.; Parrey, Mujeeb Ur Rehman

doi:10.9734/jpri/2021/v33i531179

Cited by 4 publications

(3 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[9][10][11] Multiple studies had shown that medicinal as well as aromatic plants are highest in phytochemicals, which have a variety of biological effects like antioxidant, antineoplastic, antibacterial, as well as anti-inflammatory characteristics. [12][13][14][15][16][17] The Mediterranean environment supports the development of many plant types, 1 AlQuds-Bard College, Al-Quds University, Jerusalem, Palestine 2 many which have been different ecological, biological, nutritional, as well as therapeutic properties. [18][19][20][21][22][23][24][25] Peganum harmala L. (P. harmala), native to Central Asia, Middle East, and North Africa, is a traditional treatment that has long been used in folk medicine, due to its long-standing antibacterial characteristics.…”

Section: Introductionmentioning

confidence: 99%

Assessment of the Anticancer, Antimicrobial, and Antioxidant Activities of the Peganum harmala L. Plant

Khalid,

Al-Rimawi,

Darwish

et al. 2024

Natural Product Communications

Self Cite

View full text Add to dashboard Cite

Introduction Synthetic chemical drug treatments have drawbacks including adverse effects and toxicity. Natural alternatives are sought after. Chemotherapy can be toxic. Medicinal plants offer a suggested alternative. This study examines P. harmala plant extracts for phenolic and flavonoid content, antimicrobial, antioxidant, and anticancer activities. Methods Two samples of P. harmala plant extract were prepared using ultrasonication, with ethanol concentrations of 100% and 50%. The total phenolic and flavonoid contents were determined using a chemical assay method. The antimicrobial activity of the extracts was evaluated against gram-positive bacteria ( Staphylococcus aureus and Streptococcus) and gram-negative bacteria ( Escherichia coli) using the diffusion procedure. The antioxidant impact of the extracts was assessed using the DPPH procedure. P. harmala extracts showed inhibitory effects on MCF7 breast cancer and HT29 colon cancer cell lines. Results The results of the study indicated that the P. harmala plant extracts were rich in phenolic compounds (with total phenolic content of 215.8 ± 3.5 and 155.8 ± 2.9 mg gallic acid per g extract for 50% and 100% ethanol extracts, respectively) and flavonoids (with total flavonoids content of 112.1 ± 3.1 and 92.3 ± 1.8 mg catechin per g extract) and had a high rate of antioxidant activity. The 50% ethanol extract yielded 411.8 ± 3.5 μmol trolox/g, while the 100% ethanol extract yielded 312.9 ± 8.2 μmol trolox per g extract. P. harmala extracts exhibited potent antimicrobial activity against E. coli, S. aureus, and Streptococcus. They also demonstrated strong anticancer activity, causing significant cell death in breast and colon cancer cell lines within 48 h of culturing. Conclusion P. harmala ethanolic extracts are rich in polyphenolic compounds and flavonoids, displaying high antioxidant activity. They also exhibit strong inhibitory effects against gram-positive and gram-negative bacteria and demonstrate potent anticancer activity against breast and colon cancer cell lines.

show abstract

Section: Introductionmentioning

confidence: 99%

Assessment of the Anticancer, Antimicrobial, and Antioxidant Activities of the Peganum harmala L. Plant

Khalid,

Al-Rimawi,

Darwish

et al. 2024

Natural Product Communications

Self Cite

View full text Add to dashboard Cite

show abstract

“…These achievements could result in a rise in the medication's effectiveness when given to patients. Because recently discovered chemical compounds currently need to be developed further in order to produce superior outcomes, a crucial delivery enhancement is necessary [14][15][16][17][18][19][20][21].…”

Section: Introductionmentioning

confidence: 99%

Drug Formulation of Securigera securidaca Seed Extracts

et al. 2023

View full text Add to dashboard Cite

S. securidaca seeds are reported to treat a variety of diseases; they contain multiple antidiabetic constituents and are widely used as anti-hyperglycemic, antibacterial, as well as anti-hyperlipidemic agents. The present work aimed to propose tablet formulations containing extracts of S. securidaca seeds in an attempt to obtain antibacterial and anti-hyperglycemic formulations with a more efficient oral hypoglycemic impact, limited side effects, and higher patient compliance for the first time, resulting in multiple benefits. Tablet formulations were created by encapsulating granules from S. securidaca seed extracts with varying concentrations of sodium starch glycolate as a super-disintegrant (0–3%). The final formulations were examined for weight variation, solubility, hardness, water content, disintegration time, friability, drug content (trigonelline and diosgenin), and in vitro drug release. The S. securidaca tablet formulations completed the weight test because the percentage deviation in the personal tablet weight and mechanical resistance from the mean were identified to be within the average range. In accordance with the results, formulations containing diosgenin as well as trigonelline as a super-disintegrant were identified as the ideal formulations. The amount of the active substance released from the tablet (S. securidaca seed extract formulation) was consistent throughout the results with the standard methods recommended by the FDA (94.05%) for diosgenin and 87.25% for trigonelline after 45 min. The acceptable limit, according to the FDA, is not more than (N.L.T.) 80% after 45 min for phase #1. The present study aimed to obtain an optimized formula for S. securidaca extract tablets that met the requirements of a good pharmaceutical preparation according to the United States Pharmacopeia (USP) and National Formulary (NF). This has important implications for the development of novel, effective treatments and significantly advances the development of natural medicine. Our findings are expected to be of interest to researchers, clinicians, and other experts in this field of study. Based on these findings, it can be inferred that the formulation of S. securidaca seed extracts with appropriate and compatible herbal dosage forms has fewer side effects and is more effective than traditional treatments.

show abstract

“…The high cost of conventional medicines, as well as their reported serious side effects, has prompted researchers to look for alternative treatment options for a variety of diseases [1]. Several phytochemicals have recently been described as having potent antiviral efficacy, allowing them to inhibit the rapid replication of COVID-19 [2]. These very active compounds provide hope that natural inhibitors will be discovered in the future [3].…”

Section: Introductionmentioning

confidence: 99%

The Inhibitory Potency of Major Teucrium polium Active Ingredients for the Main Protease (Mpro) of COVID-19

Al-Mazaideh

2022

JPRI

Self Cite

View full text Add to dashboard Cite

The GC/MS and docking method were used to investigate the active coronaviral protein, the Main Protease (Mpro). This coronaviral protein was tested using Autodock with phytocompounds isolated from methanol extract made from T. polium leaves. According to the GC/MS results, the leaves extract shows 8 major natural Phytochemical compounds (Hydroxytetradecanoic acid (-5.40 kcal/mol, 110.65 μM), 3-Dodecenedioic acid (-5.38 kcal/mol, 380.36 μM), D-Glucuronic (-5.20 kcal/mol, 153.64 μM), 3-Hydroxysebacic acid (-5.12 kcal/mol, 175.66 μM), Dodecen-3-ol (-4.92 kcal/mol, 247.68 μM)). As HIV-inhibitors, these phytoconstituents demonstrated good pharmaco-kinetics (ADMET) and drug-like characteristics (Remdesivir (-4.59 kcal/mol, 431.87 μM), Chloroquine (-4.68 kcal/mol, 373.83 μM), and Hydroxychloroquine (-4.22 kcal/mol, 812.81 μM)). Because they cannot cross BBB (the blood-brain barrier), the examined molecules are believed to have a strong safety profile, great absorption through the gastrointestinal system, and low central side effects. The pharmacological potentials of these lead drugs have been identified and categorized based on their LBE (lowest binding energy) and Ki (inhibition constant). The affinity of examined compounds for Main Protease (Mpro), coronaviral protein, were investigated in order to determine their use inside the active pocket of the receptor, 3CLpro. The major compounds showed greater affinity to 3CLpro than the supporting control drugs. Furthermore, the binding of all lead compounds with all the amino acids of 3CLpro are evaluated, 3-Hydroxytetradecanoic acid is the highest LBE value and lowest Ki value when compared to the approved medication as well as all other compounds under examination. These compounds could be proven as potential corona viral inhibitors. Such computational findings require additional in vitro and in vivo research.

show abstract

Molecular Docking Evaluation of the Desert Truffles as Potent Antifungal Inhibitors

Cited by 4 publications

References 17 publications

Assessment of the Anticancer, Antimicrobial, and Antioxidant Activities of the Peganum harmala L. Plant

Assessment of the Anticancer, Antimicrobial, and Antioxidant Activities of the Peganum harmala L. Plant

Drug Formulation of Securigera securidaca Seed Extracts

The Inhibitory Potency of Major Teucrium polium Active Ingredients for the Main Protease (Mpro) of COVID-19

Contact Info

Product

Resources

About